First Tracks Biotherapeutics
Price & Volume
Stats
See more52W Range | $11.30-$49.91 |
Market Cap | $1.5B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$139.6M |
Diluted EPS | -$4.74 |
News
See moreYahoo Finance • 30 days ago
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired
Yahoo Finance • 2 months ago
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch
Yahoo Finance • 3 months ago
Top Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch
Yahoo Finance • 3 months ago
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
About
CEO | Mr. Daniel R. Faga |
Address | 10770 Wateridge Circle, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 104 |